2657663
SBDFP · Branded drug packinfluenza A virus A/Darwin/11/2021 (H3N2) antigen / influenza A virus A/Georgia/12/2022 (H1N1) antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen / influenza B virus B/Singapore/WUH4618/2021 antigen Injectable Suspension [Flucelvax Quadrivalent 2023-2024]
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus A/Darwin/11/2021 (H3N2) antigen / influenza A virus A/Georgia/12/2022 (H1N1) antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen / influenza B virus B/Singapore/WUH4618/2021 antigen Injectable Suspension [Flucelvax Quadrivalent 2023-2024]?
influenza A virus A/Darwin/11/2021 (H3N2) antigen / influenza A virus A/Georgia/12/2022 (H1N1) antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen / influenza B virus B/Singapore/WUH4618/2021 antigen Injectable Suspension [Flucelvax Quadrivalent 2023-2024] is coded as 2657663 in RxNorm.
What is RxNorm code 2657663?
2657663 is the RxNorm identifier for influenza A virus A/Darwin/11/2021 (H3N2) antigen / influenza A virus A/Georgia/12/2022 (H1N1) antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen / influenza B virus B/Singapore/WUH4618/2021 antigen Injectable Suspension [Flucelvax Quadrivalent 2023-2024]. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2657663?
2657663 is a SBDFP (Branded drug pack) in RxNorm.
What is the UMLS mapping for 2657663?
2657663 maps to UMLS C5841520.